1-2 of 2
Marion Chevrier
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Results of the primary end-point of the LOC-R01: A randomized phase II Study of lenalidomide and ibrutinib in association with rituximab-methotrexate procarbazine vincristin (R-MPV) as a targeted induction treatment for patients aged 18 to 65 with a newly diagnosed primary central nervous system lymphoma (PCNSL)

Free
Carole Soussain, Caroline Houillier, Marion Chevrier, Delphine Leclercq, Joya El Haddad, Anna Schmitt, Lucie Oberic, Cécile Moluçon-Chabrot, Julie Abraham, Fabrice Jardin, Gandhi Damaj, Laurence Schenone, Jérôme Paillassa, Agathe Waultier-Rascalou, Kossi Agbetiafa, Remy Gressin, Choquet Sylvain, Thomas Gastinne, Luc Taillandier, Luc-Matthieu Fornecker, Lise Willems, Adrien Chauchet, Guido Ahle, Gabriel Antherieu, Adrien Gilbert, Khe Hoang-Xuan, Olivier Lantz, Chaimae Saji, Ana Lalanne, Herve Ghesquieres
Journal: Blood
Blood (2025) 146 (Supplement 1): 58.
https://doi.org/10.1182/blood-2025-58
Published: 2025
Journal Articles

Rituximab-Lenalidomide (REVRI) in Relapse or Refractory Primary Central Nervous System (PCNSL) or Vitreo Retinal Lymphoma (PVRL): Results of a "Proof of Concept" Phase II Study of the French LOC Network

Free
Herve Ghesquieres, MD PhD, Caroline Houillier, MD, Olivier Chinot, MD PhD, Sylvain Choquet, MD, Cecile Molucon-Chabrot, MD, Patrick Beauchene, MD, Remy Gressin, MD, Franck Morschhauser, Anna Schmitt, MD, Emmanuel Gyan, MD PhD, Khê Hoang-Xuan, MD PhD, Emmanuelle Nicolas-Virelizier, MD, Marion Chevrier, Alexia Savignoni, MD, Isabelle Turbiez, Florence Veillas, Vassili Soumelis, MD PhD, Carole Soussain, MD PhD
Journal: Blood
Blood (2016) 128 (22): 785.
https://doi.org/10.1182/blood.V128.22.785.785
Published: 2016